Drug maker tracks Real-World side effects of lupus kidney treatment
NCT ID NCT07053891
Summary
This study is a survey to monitor the safety of the drug LUPKYNIS in 400 patients with lupus nephritis (kidney inflammation from lupus) under real-world conditions. It will collect information on any side effects, how the drug is used, and its effectiveness in everyday practice. The goal is to better understand the drug's safety profile after it has been approved for use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pharmacovigilance Department
RECRUITINGOsaka, Osaka, 540-0021, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.